Topics: | AFib | Atopic Dermatitis | COPD | Lipids | Musculoskeletal | Opioids | Preventive Health | T2DM |

Updates for Migraine Management in Primary Care

Sunday, 11/18 – 11:00am – 12:20pm

Overview

Migraine is a disabling, often incapacitating, chronic neurologic disease. The diagnosis of migraine is often challenging since it is based on clinical evaluation alone. The management of migraine is multi-faceted and requires lifestyle and trigger management, along with acute and preventive treatments, or a combination thereof. Recent research has focused on the pathophysiology of migraines, in particular the role of calcitonin gene-related peptide (CGRP), which is released in significant amounts during an acute migraine attack and is chronically elevated in patients with chronic migraine.

The development of novel medications targeting the CGRP pathway may offer an effective therapy for patients with acute and chronic migraine. The CME program, Updates for Migraine Management in Primary Care, will provide primary care clinicians with the latest evidence-based strategies for migraine management and appropriate use of emerging therapies.

Learning Objectives

• Examine the epidemiology, differential diagnosis, and impact of migraine within the primary-care patient population
• Describe the pathophysiology of migraine, including the role of calcitonin gene-related peptide (CGRP)
• Delineate current standards of pharmacologic and nonpharmacologic management for the preventive and acute management of migraine
• Assess clinical safety and efficacy data for emerging therapeutic agents for the prevention and treatment of migraine

Target Audience

The intended audiences for this initiative include family medicine practitioners, primary care providers, internists, and other healthcare professionals who treat migraine.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Potomac Center for Medical Education designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please email: contact@potomacme.org

American Academy of Family Physicians (AAFP)

This Live activity, “Updates for Migraine Management in Primary Care,” from 09/29/2018 – 11/18/2018, has been reviewed and is acceptable for up to  1.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Steering Committee

Jack Schim, MD
Co-Director, The Headache Center of Southern California
Carlsbad, CA

Christopher Damiano, DO, MPH
PGY-3 Internal Medicine
Lankenau Medical Center
Wynnewood, PA

Matthew Delmonico, DO
Chief Resident, Internal Medicine Program
Lankenau Medical Center
Wynnewood, PA

Provider

Jointly provided by the Potomac Center for Medical Education and Rockpointe

Supporter

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, please visit www.lillygrantoffice.com.

Program Faculty/Steering Committee

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA